Drug Shortage Report for RITUXAN SC
| Report ID | 243448 |
| Drug Identification Number | 02457350 |
| Brand name | RITUXAN SC |
| Common or Proper name | RITUXIMAB |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | RITUXIMAB |
| Strength(s) | 1400MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 X VIAL |
| ATC code | L01FA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-11-29 |
| Actual start date | |
| Estimated end date | 2024-12-13 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-11-30 | English | Compare |
| v4 | 2024-11-26 | French | Compare |
| v3 | 2024-11-26 | English | Compare |
| v2 | 2024-11-19 | French | Compare |
| v1 | 2024-11-19 | English | Compare |
Showing 1 to 5 of 5